Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The North America GLP-1 receptor agonist market dominated the revenue with 75.46% share in 2025, supported by a high prevalence of metabolic disorders, early adoption of novel therapeutics, and a well-established healthcare infrastructure
Intended Use: For Laboratory Research Use Only Key Characteristics of Semaglutide (2 mg) A synthetic GLP-1 receptor agonist analog designed for experimental use Structurally modified for enhanced stability in research settings Lipid conjugation enables prolonged receptor interaction in vitro High analytical purity, confirmed by HPLC and mass spectrometry Supplied as lyophilized powder to preserve structural integrity before reconstitution Suitable for studies in endocrine, metabolic, and receptor signaling research Compatible with standard peptide handling and analytical workflows How Semaglutide (2 mg) Supports Research Semaglutide (2 mg) is used in laboratories to study GLP-1 receptor signaling and its role in metabolism
This balance underscores why multiple trial arms were necessary: without testing a range of dosages, investigators would not have uncovered these differences in outcome patterns
Armed with these, in early 1984 she set out to develop an RIA to detect their presence within the gut and pancreas
Plant Cell Physiol 33:541553 Mller IM, Jensen PE, Hansson A (2007) Oxidative modifications to cellular components in plants
In its therapeutic form, GLP-1 receptor agonists mimic this hormone, offering a powerful approach to weight loss
